|
Article Cited by others EDITORIAL
The World Association of Radiopharmaceutical and Molecular Therapy position statement on the initial radioiodine therapy for differentiated thyroid carcinoma
Dizdarevic S, Tulchinsky M, McCready V R, Mihailovic J, Vinjamuri S, Buscombe J R, Lee S T, Frangos S, Sathekge M, Siraj Q, Choudhury P, Bom H, Franceschi M, Ugrinska A, Paez D, Hussain R, Mailman J, Luster M, Virgolini I, On behalf of the WARMTH Thyroid Group
Year : 2019| Volume: 18| Issue : 2 | Page no: 123-126 | This article has been cited by | | 1 |
Contemporary considerations in adjuvant radioiodine treatment of adults with differentiated thyroid cancer |
|
| | Malik E. Juweid,Mark Tulchinsky,Ayman Mismar,Munther Momani,Ayman A. Zayed,Hussam Al Hawari,Nader Albsoul,Felix M. Mottaghy | | | International Journal of Cancer. 2020; | | | [Pubmed] [Google Scholar] [DOI] | | | 2 |
Radiotheragnostics Paradigm for Radioactive Iodine (Iodide) Management of Differentiated Thyroid Cancer |
|
| | Einat Slonimsky,Mark Tulchinsky | | | Current Pharmaceutical Design. 2020; 26(31): 3812 | | | [Pubmed] [Google Scholar] [DOI] | |
|
|
|
|
Users Online: 589 
